To compare surgery with definitive chemoradiotherapy for patients with resectable cervical esophageal squamous cell carcinoma.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
192
Patients receive esophagectomy or definitive chemoradiotherapy according to patient preference
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, China
RECRUITINGOverall Survival
5 year overall survival
Time frame: 5 years after surgery or definitive Chemoradiotherapy is completed
Laryngo-esophageal dysfunction free survival
5 year laryngo-esophageal dysfunction free survival
Time frame: 5 years after surgery or definitive Chemoradiotherapy is completed
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.